Skip to content
Announcement:

Latest Publication: Read our teams’ latest paper in Antibiotics, showing reduced nephrotoxicity of a novel formulation of polymyxin B compared to the clinical formulation using a validated primary human proximal tubule cell model.

3rd Annual Gene Therapy for Ophthalmic Disorders

Date

3rd October 2023 - 5 October, 2023

Location

Boston, MA

Venue

TBC

The 3rd Annual Gene Therapy for Ophthalmic Disorders meeting brings world class content, bringing two tracks of learning to tackle the pressing challenges faced in the pre-clinical stages and in clinical development. This includes challenges faces with drug targets including wet AMD, dry AMD, DME, IRDs and more.

Find out more

Share on social media:

Don't miss out on our latest innovations: follow us on Linkedin

Get our latest updates straight to your inbox